These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 20013094)

  • 21. Antimicrobial susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in health care-associated urinary tract infection: focus on susceptibility to fosfomycin.
    Cho YH; Jung SI; Chung HS; Yu HS; Hwang EC; Kim SO; Kang TW; Kwon DD; Park K
    Int Urol Nephrol; 2015 Jul; 47(7):1059-66. PubMed ID: 26026972
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stratification by demographic and clinical data of the antibiotic susceptibility of Escherichia coli from urinary tract infections of the community.
    Grados MC; Thuissard IJ; Alós JI
    Aten Primaria; 2019 Oct; 51(8):494-498. PubMed ID: 30104087
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of 3789 in- and outpatient Escherichia coli isolates from across Canada--results of the CANWARD 2007-2009 study.
    Lagacé-Wiens PR; Simner PJ; Forward KR; Tailor F; Adam HJ; Decorby M; Karlowsky J; Hoban DJ; Zhanel GG;
    Diagn Microbiol Infect Dis; 2011 Mar; 69(3):314-9. PubMed ID: 21353959
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Escherichia coli antibiotic resistance in emergency departments. Do local resistance rates matter?
    Grignon O; Montassier E; Corvec S; Lepelletier D; Hardouin JB; Caillon J; Batard E;
    Eur J Clin Microbiol Infect Dis; 2015 Mar; 34(3):571-7. PubMed ID: 25339200
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The burden of antimicrobial resistance among urinary tract isolates of Escherichia coli in the United States in 2017.
    Critchley IA; Cotroneo N; Pucci MJ; Mendes R
    PLoS One; 2019; 14(12):e0220265. PubMed ID: 31821338
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibiotic resistance pattern of Escherichia coli isolates from outpatients with urinary tract infections in Somalia.
    Mohamed MA; Abdifetah O; Hussein FA; Karie SA
    J Infect Dev Ctries; 2020 Mar; 14(3):284-289. PubMed ID: 32235089
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fluoroquinolone resistance mechanisms in urinary tract pathogenic Escherichia coli isolated during rapidly increasing fluoroquinolone consumption in a low-use country.
    Christiansen N; Nielsen L; Jakobsen L; Stegger M; Hansen LH; Frimodt-Møller N
    Microb Drug Resist; 2011 Sep; 17(3):395-406. PubMed ID: 21668371
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quinolone resistance in female outpatient urinary tract isolates of Escherichia coli: age-related differences.
    Gobernado M; Valdés L; Alós JI; Garcia-Rey C; Dal-Ré R; García-de-Lomas J;
    Rev Esp Quimioter; 2007 Jun; 20(2):206-10. PubMed ID: 17893757
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk factors for resistance to ciprofloxacin in community-acquired urinary tract infections due to Escherichia coli in an elderly population.
    Mulder M; Kiefte-de Jong JC; Goessens WH; de Visser H; Hofman A; Stricker BH; Verbon A
    J Antimicrob Chemother; 2017 Jan; 72(1):281-289. PubMed ID: 27655855
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Cohort Study of Risk Factors That Influence Empirical Treatment of Patients with Acute Pyelonephritis.
    Bosch-Nicolau P; Falcó V; Viñado B; Andreu A; Len O; Almirante B; Pigrau C
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28971876
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factors associated with ciprofloxacin-resistant Escherichia coli urinary tract infections in discharged ED patients.
    Kratochwill L; Powers M; McGraw MA; King L; O'Neill JM; Venkat A
    Am J Emerg Med; 2015 Oct; 33(10):1473-6. PubMed ID: 26302942
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antimicrobial resistance of Escherichia coli isolates from outpatient urinary tract infections in women in six European countries including Russia.
    Ny S; Edquist P; Dumpis U; Gröndahl-Yli-Hannuksela K; Hermes J; Kling AM; Klingeberg A; Kozlov R; Källman O; Lis DO; Pomorska-Wesołowska M; Saule M; Wisell KT; Vuopio J; Palagin I;
    J Glob Antimicrob Resist; 2019 Jun; 17():25-34. PubMed ID: 30447337
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of Urine Matrix and pH on the Potency of Delafloxacin and Ciprofloxacin against Urogenic Escherichia coli and Klebsiella pneumoniae.
    So W; Crandon JL; Nicolau DP
    J Urol; 2015 Aug; 194(2):563-70. PubMed ID: 25637857
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fluoroquinolone-resistant urinary isolates of Escherichia coli from outpatients are frequently multidrug resistant: results from the North American Urinary Tract Infection Collaborative Alliance-Quinolone Resistance study.
    Karlowsky JA; Hoban DJ; Decorby MR; Laing NM; Zhanel GG
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2251-4. PubMed ID: 16723598
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk factors for resistance to "first-line" antimicrobials among urinary tract isolates of Escherichia coli in children.
    Allen UD; MacDonald N; Fuite L; Chan F; Stephens D
    CMAJ; 1999 May; 160(10):1436-40. PubMed ID: 10352632
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nitrofurantoin retains antimicrobial activity against multidrug-resistant urinary Escherichia coli from US outpatients.
    Sanchez GV; Baird AM; Karlowsky JA; Master RN; Bordon JM
    J Antimicrob Chemother; 2014 Dec; 69(12):3259-62. PubMed ID: 25063776
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Microbiology and Drug Resistance of Pathogens in Patients Hospitalized at the Nephrology Department in the South of Poland.
    Michno M; Sydor A; Wałaszek M; Sułowicz W
    Pol J Microbiol; 2018; 67(4):517-524. PubMed ID: 30550238
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro activity of fosfomycin against ciprofloxacin-resistant or extended-spectrum beta-lactamase-producing Escherichia coli isolated from urine and blood.
    Ko KS; Suh JY; Peck KR; Lee MY; Oh WS; Kwon KT; Jung DS; Lee NY; Song JH
    Diagn Microbiol Infect Dis; 2007 May; 58(1):111-5. PubMed ID: 17300900
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Emerging Escherichia coli O25b/ST131 clone predicts treatment failure in urinary tract infections.
    Can F; Azap OK; Seref C; Ispir P; Arslan H; Ergonul O
    Clin Infect Dis; 2015 Feb; 60(4):523-7. PubMed ID: 25378460
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of a Stewardship-Initiated Restriction on Empirical Use of Ciprofloxacin on Nonsusceptibility of Escherichia coli Urinary Isolates to Ciprofloxacin.
    O'Brien KA; Zhang J; Mauldin PD; Gomez J; Hurst JM; Sean Boger M; Bosso JA
    Pharmacotherapy; 2015 May; 35(5):464-9. PubMed ID: 26011139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.